NCT01364051 2026-03-18Cediranib Maleate and Selumetinib Sulfate in Treating Patients With Solid MalignanciesNational Cancer Institute (NCI)Phase 1 Active not recruiting19 enrolled
NCT00750841 2026-02-23Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid TumoursAstraZenecaPhase 1 Active not recruiting64 enrolled